Incomplete harms reporting in systematic reviews of direct oral factor Xa inhibitors.
- DOI
- 10.1182/bloodadvances.2025017363
- Published
- 2025 Oct 28
- Container
- Blood advances
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2025017363,
title = {Incomplete harms reporting in systematic reviews of direct oral factor Xa inhibitors.},
author = {Rea J and Lee C and Kee M and Rucker B and Flores H and Walters C and Haney T and Tomlin A and Khan A and Vassar M},
year = {2025},
journal = {Blood advances},
doi = {10.1182/bloodadvances.2025017363},
url = {https://doi.org/10.1182/bloodadvances.2025017363}
}RIS
TY - JOUR TI - Incomplete harms reporting in systematic reviews of direct oral factor Xa inhibitors. AU - Rea J AU - Lee C AU - Kee M AU - Rucker B AU - Flores H AU - Walters C AU - Haney T AU - Tomlin A AU - Khan A AU - Vassar M PY - 2025 JO - Blood advances DO - 10.1182/bloodadvances.2025017363 UR - https://doi.org/10.1182/bloodadvances.2025017363 ER -
APA
J, R., C, L., M, K., B, R., H, F., C, W., T, H., A, T., A, K., & M, V. (2025). Incomplete harms reporting in systematic reviews of direct oral factor Xa inhibitors.. Blood advances. https://doi.org/10.1182/bloodadvances.2025017363
Source records
- pubmed · retrieved 2026-09-26T01:31:49.492Z